Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hulic Conference

Aug 19, 2019 9:30 AM - Aug 20, 2019 5:00 PM

Hulic Asakusabashi Building, 1-22-16 Asakusa, Taito-ku, Tokyo, 111-0053 Japan

6th DIA European Medicines Regulations Training Course

This course will give you an overview of the European regulatory system to provide you with the tools you need to develop a successful regulatory strategy.

Overview

Online Registration has been closed. Onsite Registration will be available at Hulic Asakusabashi building.

Click Here to View the Program

This course will give you an overview of the European regulatory system to provide you with the tools you need to develop a successful regulatory strategy. You will be given information about the different routes for obtaining a license for the European market, including centralized or decentralized procedures; mutual recognition procedures; national procedures; and the specific procedures for orphan drugs, pediatrics, advanced therapies, and combination products. The course will cover the different steps and time lines for each procedure, the clockstops, the compiling of questions, and other key topics.

You’ll also receive a brief introduction to the unique set up of the European regulatory environment, including the different responsibilities of the European Commission, the member states, the European Medicines Agency (EMA), the National Competent Authorities (NCAs), and the Heads of Medicines Agencies (HMA).

Please note: the language of this training course will be English only, but Japanese speaking will be welcomed during group discussions.

Program Committee

  • Masayoshi  Higuchi
    Masayoshi Higuchi Head of Quality & Regulatory Compliance Unit,
    Chugai Pharmaceutical Co., Ltd., Japan
  • Akiko  Ikeda, RPh
    Akiko Ikeda, RPh
    KalVista Pharmaceuticals Japan K.K., Japan
  • Yumi  Inukai
    Yumi Inukai New Drug Regulatory Affairs Dept.
    Daiichi Sankyo Co., Ltd., Japan
  • Miyuki  Kaneko
    Miyuki Kaneko Japan Regulatory Portfolio Lead, Regulatory Affairs
    Pfizer R&D Japan G.K., Japan
  • Yomei  Matsuoka, MSc, RPh
    Yomei Matsuoka, MSc, RPh Vice President, Pharmacoepidemiology and PMS Department
    Daiichi Sankyo Co., Ltd., Japan
  • Miwa  Tamada
    Miwa Tamada Manager, New Drug RA Department, Regulatory Affairs
    GlaxoSmithKline K.K., Japan

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.